Cargando…

Evaluation of Short Term Clinical Effects and Presumptive Mechanism of Botulinum Toxin Type A as a Treatment Modality of Benign Prostatic Hyperplasia

The purpose of this study was to evaluate the effect and investigate the putative mechanism of botulinum toxin type A (BTA) applied to the treatment of benign prostatic hyperplasia (BPH). A total of 52 patients with symptomatic BPH were evaluated. Transperineal intraprostatic injection under transre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Dong Soo, Cho, Taek Woo, Lee, Yong Kyu, Lee, Young Tae, Hong, Young Kwon, Jang, Woong Ki
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2006
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687757/ https://www.ncbi.nlm.nih.gov/pubmed/17066515 http://dx.doi.org/10.3349/ymj.2006.47.5.706

Ejemplares similares

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009)

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection
por: Ergün, Osman, et al.
Publicado: (2017)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Intradermal Injection of Botulinum Toxin: A Safer Treatment Modality for Forehead Wrinkles
por: Jun, Ji-Young, et al.
Publicado: (2018)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Relationship between Intravesical Prostatic Protrusion and Postoperative Outcomes in Patients with Benign Prostatic Hyperplasia
por: Lee, Jong Woo, et al.
Publicado: (2012)

Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities
por: Al Khayal, Abdullah M, et al.
Publicado: (2021)

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
por: Hsu, Yu-Chao, et al.
Publicado: (2016)

Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study
por: Kim, Jeong Ho, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
por: Chiang, Bing-Juin, et al.
Publicado: (2019)

Application of the Modified Clavien Classification System to 402 Cases of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Choi, Jong In, et al.
Publicado: (2014)

Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea
por: Jo, Jung Ki, et al.
Publicado: (2021)

Heat-Killed and Live Enterococcus faecalis Attenuates Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
por: Choi, Young-Jin, et al.
Publicado: (2021)

Changes in Nocturia after Photoselective Vaporization of the Prostate for Patients with Benign Prostatic Hyperplasia
por: Lee, Chang Ju, et al.
Publicado: (2010)

Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses
por: Arnouk, René, et al.
Publicado: (2012)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh, Farzad, et al.
Publicado: (2020)

Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea
por: Lee, Young Ju, et al.
Publicado: (2016)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Seasonal Variation of Urinary Symptoms in Korean Men with Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
por: Choi, Ho Chul, et al.
Publicado: (2015)

Relationship Between Chronic Periodontitis and Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia
por: Hyun, Hana, et al.
Publicado: (2021)

DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia
por: Kim, Stephanie S., et al.
Publicado: (2023)

Influence of Panax ginseng on Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia
por: Kim, Su Kang, et al.
Publicado: (2014)

The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)

Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study
por: Park, Dong Jin, et al.
Publicado: (2023)

120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity
por: Choi, Sae Woong, et al.
Publicado: (2011)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009–2016
por: Park, Sewon, et al.
Publicado: (2022)

Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
por: Shin, Yu Seob, et al.
Publicado: (2021)

AB016. Which laser works best for benign prostatic hyperplasia?
por: Kim, Sae Woong
Publicado: (2015)

Effects of Panax ginseng on the nerve growth factor expression in testosterone induced benign prostatic hyperplasia
por: Kim, Su Kang, et al.
Publicado: (2018)

Reply to Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
por: Jo, Jung Ki, et al.
Publicado: (2021)

Robotic-assisted simple prostatectomy after prostatic arterial embolization for large benign prostate hyperplasia: Initial experience
por: Kam, Sung-Chul, et al.
Publicado: (2022)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
por: Oh, Sung-hee, et al.
Publicado: (2020)

Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels
por: Kim, Won Tae, et al.
Publicado: (2011)

Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study
por: Kim, Bum Soo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1esiqgna9g2t438lisv9nggikh